Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Amitabh Das Shukla (Allahabad, India), Amitabh Das Shukla, Abhinav Chaudhary, Tariq Mahmood, Alok Chandra. MDR-TB: Early screening or future screaming. Eur Respir J 2016; 48: Suppl. 60, 2746

Member's Comments

No comment yet.

Related content which might interest you: Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 MDR-TB management: what is new? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Challenges in the prevention, diagnosis, and treatment of tuberculosis in children Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Rapid monitoring of tuberculosis treatment response: A multi-centre study Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016 Interim report: The effectiveness of smoking cessation in tuberculosis patients and its effective factor Source: International Congress 2016 – Smoking cessation strategies Year: 2016 Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Pneumonia: diagnosis, treatment and prevention Source: International Congress 2018 – State of the art session: Respiratory infections Year: 2018 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Modern characteristics of childhood tuberculosis Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Rifampicin-resistant TB on Gene Xpert: What is the best empiric combination treatment while awaiting cultures? Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Could side effects of MDR-TB treatment change the outcome of the disease? Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible? Source: International Congress 2015 – Paediatric bronchology Year: 2015 Reasons for suspicion of prostate tuberculosis Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 The information value of DIASKINTEST in diagnostics of pediatric TB Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013